2010
Intravascular Ultrasound Findings of Stent Fractures in Patients With Sirolimus- and Paclitaxel-Eluting Stents
Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA, Parise H, Mehran R, Leon MB, Moses JW, Stone GW. Intravascular Ultrasound Findings of Stent Fractures in Patients With Sirolimus- and Paclitaxel-Eluting Stents. The American Journal Of Cardiology 2010, 106: 952-957. PMID: 20854956, DOI: 10.1016/j.amjcard.2010.05.024.Peer-Reviewed Original ResearchConceptsPaclitaxel-eluting stentsIntravascular ultrasound findingsSirolimus-eluting stentsUltrasound findingsStent fractureExternal elastic membrane areaClinical trial cohortSimilar frequencyComplete stent fracturePE fractureTrial cohortInstitutional cohortIVUS findingsStent lengthDistal fragmentIVUS featuresIVUS analysisCalcified plaquesStent fragmentsPatientsStrut fractureStentsMalalignmentCohortFractures
2006
Volumetric Intravascular Ultrasound Assessment of Neointimal Hyperplasia and Nonuniform Stent Strut Distribution in Sirolimus-Eluting Stent Restenosis
Sano K, Mintz GS, Carlier SG, Fujii K, Takebayashi H, Kimura M, Costa JR, Tanaka K, Costa RA, Lui J, Weisz G, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Volumetric Intravascular Ultrasound Assessment of Neointimal Hyperplasia and Nonuniform Stent Strut Distribution in Sirolimus-Eluting Stent Restenosis. The American Journal Of Cardiology 2006, 98: 1559-1562. PMID: 17145209, DOI: 10.1016/j.amjcard.2006.07.030.Peer-Reviewed Original ResearchConceptsMinimum lumen siteStent restenotic lesionsStent areaDiabetes mellitusLumen areaRestenotic lesionsStent strut distributionIH areaMinimal lumen area siteSirolimus-eluting stent implantationVolumetric intravascular ultrasound analysisIntravascular ultrasound assessmentMinimum stent areaIntravascular ultrasound analysisMinimum lumen areaMinimal lumen areaMinimal lumen siteIH responseSES implantationStent implantationUltrasound assessmentStent lengthNeointimal hyperplasiaStent restenosisStrut distribution
2005
Intravascular Ultrasonic Assessment of Stent Diameters Derived from Manufacturer’s Compliance Charts
de Ribamar Costa J, Mintz GS, Carlier SG, Costa RA, Fujii K, Sano K, Kimura M, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Intravascular Ultrasonic Assessment of Stent Diameters Derived from Manufacturer’s Compliance Charts. The American Journal Of Cardiology 2005, 96: 74-78. PMID: 15979438, DOI: 10.1016/j.amjcard.2005.02.049.Peer-Reviewed Original ResearchConceptsManufacturers' compliance chartsMinimum stent diameterCompliance chartsStent diameterIntravascular ultrasoundStent sizeDe novo coronary lesionsDeployment pressureNovo coronary lesionsMinimal stent diameterHuman coronary arteriesStent manufacturersCoronary lesionsIVUS guidanceCoronary arteryStent lengthInterventional cardiologistsPhysician reportsPercutaneous proceduresStent overlapDifferent stent lengthsStentsBoston ScientificUltrasonic assessmentBare metal
2001
Stent Thrombosis in the Modern Era
Cutlip D, Baim D, Ho K, Popma J, Lansky A, Cohen D, Carrozza J, Chauhan M, Rodriguez O, Kuntz R. Stent Thrombosis in the Modern Era. Circulation 2001, 103: 1967-1971. PMID: 11306525, DOI: 10.1161/01.cir.103.15.1967.Peer-Reviewed Original ResearchMeSH KeywordsAspirinBlood Vessel Prosthesis ImplantationCausalityCoronary DiseaseCoronary ThrombosisEndpoint DeterminationFemaleGraft Occlusion, VascularHumansIncidenceLogistic ModelsMaleMiddle AgedMulticenter Studies as TopicMyocardial RevascularizationOdds RatioPlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicSurvival RateTiclopidineTreatment OutcomeConceptsTotal stent lengthStent thrombosisAntiplatelet therapyStent lengthClinical consequencesFinal minimal lumen diameterLumen diameterNative coronary artery lesionsAngiographic stent thrombosisClinical stent thrombosisHigh-pressure deploymentRoutine antiplatelet therapyCoronary artery lesionsIncidence of deathMinimal lumen diameterProcedure-related variablesSecond-generation stentsCoronary stent trialsSerious clinical consequencesFinal lumen diameterNonrandomized registryAntithrombotic regimensArtery lesionsPersistent dissectionMyocardial infarction
2000
Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials)
Kereiakes D, Linnemeier T, Baim D, Kuntz R, O’Shaughnessy C, Hermiller J, Fink S, Lansky A, Nishimura N, Broderick T, Popma J. Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials). The American Journal Of Cardiology 2000, 86: 336-341. PMID: 10922447, DOI: 10.1016/s0002-9149(00)00928-0.Peer-Reviewed Original Research
1999
Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment
Kereiakes D, Midei M, Hermiller J, O’Shaughnessy C, Schlofmitz R, Yakubov S, Fink S, Hu F, Nishimura N, Sievers M, Valentine M, Broderick T, Lansky A, Moses J. Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment. The American Journal Of Cardiology 1999, 84: 1385-1390. PMID: 10606109, DOI: 10.1016/s0002-9149(99)00581-0.Peer-Reviewed Original ResearchConceptsPrimary end pointMinimal lumen diameterMulti-Link stentComposite primary end pointPostprocedural minimal lumen diameterLumen diameterEnd pointMajor cardiac eventsProspective multicenter registryQuantitative coronary angiographyCoronary stent deploymentMultivariate regression modelingAngiographic restenosisMulticenter registryAngiographic outcomesCardiac eventsCurrent smokingCoronary angiographyDiabetes mellitusIndependent predictorsLesion eccentricityProcedural successTarget stenosisStent lengthLate outcomes